Hostname: page-component-74656f9884-6grmk Total loading time: 0 Render date: 2026-11-06T09:58:52.276Z Has data issue: false hasContentIssue false
  • English
  • Français

Effects of kisspeptin on the maturation of human ovarian primordial follicles in vitro

Published online by Cambridge University Press:  15 December 2023

Fatemeh Rezaei-Tazangi Open the ORCID record for Fatemeh Rezaei-Tazangi [Opens in a new window] ,
Leila Kooshesh ,
Ali Tayyebiazar ,
Neda Taghizabet ,
Anahita Tavakoli Open the ORCID record for Anahita Tavakoli [Opens in a new window] ,
Ashraf Hassanpour ,
Fereshteh Aliakbari ,
Ebrahim Kharazinejad  and
Ali-Mohammad Sharifi
Fatemeh Rezaei-Tazangi
Affiliation:
Department of Anatomy, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran
Leila Kooshesh
Affiliation:
Department of Genetics, Fars Academic Center for Education, Culture and Research, ACECR, Shiraz, Iran
Ali Tayyebiazar
Affiliation:
Clinical Research Development Unit of Imam Khomeini Hospital, Urmia University of Medical Sciences, Urmia, I.R. Iran
Neda Taghizabet
Affiliation:
Men’s Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Anahita Tavakoli
Affiliation:
Department of Biology, Faculty of Science, Arak University, Arak, Iran
Ashraf Hassanpour
Affiliation:
Anatomical Department, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran
Fereshteh Aliakbari*
Affiliation:
Men’s Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Ebrahim Kharazinejad
Affiliation:
Department of Anatomy, Faculty of Medicine, Abadan University of Medical Sciences, Abadan, Iran
Ali-Mohammad Sharifi
Affiliation:
Clinical Research Development Center, Shahid Modarres Educational Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
*
Corresponding author: Fereshteh Aliakbari; Email: fereshtehaliakbari60@gmail.com
Rights & Permissions [Opens in a new window]

Summary

At this time, with advances in medical science, many cancers and chronic diseases are treatable, but one of their side effects is infertility. Some women also want to delay pregnancy for personal reasons. There has been some evidence that kisspeptin activates broad signals by binding to its receptor, suggesting that the role of kisspeptin in direct control of ovarian function includes follicle growth and steroid production. In this study, the effect of kisspeptin on improving the quality and results for human ovarian follicles was investigated. A section of ovary was removed laparoscopically from women between 20 and 35 years of age (n = 12). Pieces were divided randomly into two groups, control and treatment (with 1 μM kisspeptin). Real-time PCR was performed for GDF9, BMP15 and mTOR gene expression assessments. Western blotting was carried out to measure AKT and FOXO3a protein expression. Data were analyzed using one-way analysis of variance (ANOVA) and Tukey’s test; means were considered significantly different at a P-value < 0.05. During treatment with the kisspeptin group, maturity genes are expressed. Therefore, kisspeptin is an effective substance to improve the quality of the human ovarian medium as it increases the maturity of follicles.

Keywords

BMP15Follicle maturationGDF9Human ovarian folliclesKisspeptin

Information

Type
Research Article
Information
Zygote , Volume 32 , Issue 1 , February 2024 , pp. 66 - 70
Check for updates
Copyright
© The Author(s), 2023. Published by Cambridge University Press

Introduction

At this time, one strategy to maintain fertility in women who are facing the risk of ovarian function loss, including women with cancer (in which loss is due to chemotherapy and radiation therapy), is to freeze ovarian tissue and transplant it after recovery. However in many cases, especially in women with leukaemia, there are malignant cells in the ovary, so re-transplantation of ovarian tissue is not a good option if the follicles inside the tissue can potentially grow in vitro (Jadoul et al., Reference Jadoul, Dolmans and Donnez2010; Donnez et al., Reference Taniguchi, Kuwahara, Tachibana, Yano, Yano, Yamamoto, Yamasaki, Iwasa, Hinokio, Matsuzaki and Irahara2017; Rivas Leonel et al., Reference Rivas Leonel, Lucci and Amorim2019). Primary follicles have special benefits for premenopausal girls who have undergone chemotherapy. Currently, the only preservation option for girls before puberty is ovarian tissue storage and transplantation after complete recovery (Wallace et al., Reference Wallace, Smith, Kelsey, Edgar and Anderson2014; Shi et al., Reference Shi, Xie, Wang and Li2017). Although the follicle matures in the connective tissue, it has little ability to fertilize or implant so, to date, only 60 live births worldwide have been reported from transplanted frozen ovarian tissue (Ramezani et al., Reference Ramezani, Salehnia and Jafarabadi2017; Taghizabet et al., Reference Taghizabet, Khalili, Anbari, Agha-Rahimi, Nottola, Macchiarelli and Palmerini2018). There is also the possibility of cancer cells re-emerging if ovarian tissue is transplanted. Conversely, it has been clinically proven that the duration of activity of a thawed frozen ovary that is transplanted to a person is from 9 months to 3 years, while there is a two-thirds reduction in follicles due to ischaemia resulting from transplantation. Therefore, transplantation of thawed frozen ovarian tissue is not a suitable method for some patients. For these women, in vitro culture of follicles derived from ovarian tissue is recommended as the majority of ovarian cortex follicles are inactive primordial follicles (Choi et al., Reference Choi, Lee, Lee, Yoon, Bae and Choi2007; Mazoochi et al., Reference Mazoochi, Salehnia, Pourbeiranvand, Forouzandeh, Mowla and Hajizadeh2009; Kona et al., Reference Kona, Praveen Chakravarthi, Siva Kumar, Srividya, Padmaja and Rao2016). Recent research has shown that culture of the human ovary cortex containing primordial follicles significantly changes inactive primordial follicles to existing follicles and growth occurs in a short period of 6–10 days.

When the primordial follicles in the ovarian cortex begin to grow, they reach the multilayered stage but do not survive. There are several culture media for follicle (egg) growth in the laboratory. Among them, there has been only one successful report for the human primordial follicle to the stage of meiosis puberty, but in this report the meiotic spindle was defective and fertilization did not occur (Kotani et al., Reference Kotani, Detheux, Vandenbogaerde, Communi, Vanderwinden, Le Poul, Brézillon, Tyldesley, Suarez-Huerta, Vandeput, Blanpain, Schiffmann, Vassart and Parmentier2001; Ebrahimi et al., Reference Ebrahimi, Valojerdi, Eftekhari-Yazdi, Baharvand and Farrokhi2010; Trapphoff et al., Reference Trapphoff, Heiligentag, Simon, Staubach, Seidel, Otte, Fröhlich, Arnold and Eichenlaub-Ritter2016).

In one animal study on mice, there was only one live birth but this exhibited defects such as obesity; however, proof of concept showed that full development of human eggs could occur in vitro (Skorupskaite et al., Reference Skorupskaite, George and Anderson2014) Further optimization and morphological evaluation are needed to determine whether the eggs were normal. Therefore, any study to optimize culture media will be valuable. Because kisspeptin (metastin) is a neuropeptide produced in the hypothalamic axis and made by two populations of neurons in the hypothalamus, it affects egg and ovarian maturation in vivo. Its gene (KISS1) is located on chromosome 1q32.11 and modulates the expression of the antioxidant enzymes against oxidant agents; it also regulates puberty and reproductive activities through its membrane receptors coupled with G protein (Kotani et al., Reference Kotani, Detheux, Vandenbogaerde, Communi, Vanderwinden, Le Poul, Brézillon, Tyldesley, Suarez-Huerta, Vandeput, Blanpain, Schiffmann, Vassart and Parmentier2001). Kisspeptin triggers the hypothalamic–pituitary–gonadal axis, inducing gametogenesis by releasing follicle-stimulating hormone (FSH) and luteinizing hormone (LH) through the pituitary gland. Many studies have demonstrated the role of kisspeptin in ovarian function control, such as follicular development, steroidogenesis, oocyte maturation, and ovulation (Aslan et al., Reference Aslan, Erkanli Senturk, Akkaya, Sahin and Yılmaz2017; MacManes et al., Reference MacManes, Austin, Lang, Booth, Farrar and Calisi2017).

In a study in 2018, convincing evidence showed that kisspeptin activated broad signals by binding to its receptor, suggesting a role for kisspeptin in the direct control of ovarian function. The results obtained from this study showed that the intraovarian kisspeptin/KISS1R system modulated granulosa cell proliferation and apoptosis, oocyte maturation, ovulation, and steroidogenesis by regulating the mitogen-activated protein kinase (MAPK) signalling pathway. In addition to the MAPK pathway, the PI3K/Akt pathway also functions in both granulosa cells and oocytes (Hu et al., Reference Hu, Zhao, Chang, Yu and Qiao2017; Cao et al., Reference Cao, Li, Jiang, Ling and Kuang2019).

Materials and methods

Twelve healthy ovaries from women aged 25–40 years who had undergone hysterectomy and had their fallopian tubes closed were used after pathology examination to ensure the health of ovarian tissue. Ovarian tissue was transferred to a culture medium containing sodium pyruvate (2 mM), glutamine (2 mM), human serum albumin (3 mg/ml), penicillin G (75 μg/ml), and streptomycin (50 μg/ml).

Ovarian tissue culture

Ovarian tissue was transferred to fresh culture medium, observed under a microscope, and extra tissue and blood clots were removed. The resulting tissue was divided into 1 × 1 × 0.5 mm square pieces. Finally, the samples were cultured in 24-well plates. Here 300 μl of culture medium containing HEPES, glutamine, penicillin, streptomycin, transferrin, selenium, and human insulin in the sham group w added to each well. In groups treated with kisspeptin, doses of 35 or 40 pmol of kisspeptin were added to the culture medium. The culture plates were incubated for 37 days at 37°C and 5% CO2. After 8 days, growing follicles were observed on the surface of the tissue.

Evaluation of phosphorylation of FOXO3/Bax and ATK by western blotting

At the end of the ovarian tissue treatment period, the surface of the Petri dishes was then washed twice with cold PBS, and then 100 μl of lubricating buffer containing 2.25 ml RIPA buffer, 50 μl protease inhibitor, 50 μl orthovanadate, and 250 μl sodium fluoride were added to each Petri dish. With the help of a scraper, the tissue was collected and transferred into a microtube. The details of the protocol were carried out according to the study by Qin et al. (Reference Qin, Zhao, Zhang, Yin, Qiao, Guo and Lu2022). Antibody cat. nos.: AKT, #9272; FOXO3, SC-48348; GAPDH, GTX100118; secondary antibody (rabbit), BA1054-2; secondary antibody (mouse) SC-516102.

Investigation of gene expression for mTORC, BMP15, GDF9 and MOS by RT-PCR

Expression levels of genes mTORC, BMP15, GDF9 and MOS was evaluated by RT-PCR in four groups, using RT-PCR, and after mRNA extraction and cDNA synthesis. RNA was extracted from each replicate of the treatments using a Qiagen microkit according to the manufacturer’s recommended instructions. cDNA synthesis was performed using a Qiagen cDNA synthesis kit according to the manufacturer’s instructions. The primers were designed using Primer Design software and their specificity was verified by the NCBI site. After replication efficiency, gene expression was assessed using specific primers and SYBR green. Threshold cycle values of target genes compared with host genes were corrected and the relative expression of the gene was calculated using the 2−ΔΔCt method.

Results

Gene expression

BMP15

As can be seen in Figure 1, in the treatment group, the expression level is also higher than in the control group (P < 0.05; Figure 1).

Figure 1.

mRNA expression levels of BMP15 in experimental groups. Different lowercase letters (a and b) indicate a significant difference between groups.

GDF9

Real-time PCR was used to evaluate the effect of kisspeptin on the expression of follicle maturity genes. The characteristics of the primers used are given in Table 1. In the treatment group, the expression level was higher than in the control group and its difference compared with all groups was significant (P < 0.05; Figure 2).

Table 1.

The primer sequences of target genes

Figure 2.

mRNA expression levels of GDF9 in experimental groups. Different lowercase letters (a and b) indicate a significant difference between groups.

mTOR

In the treatment group, the expression levels of mTOR and MOS were lower than in the control group (P < 0.05; Figures 3 and 4).

Figure 3.

mRNA expression levels of mTOR in experimental groups. ‘*’ indicates a significant difference between groups at P < 0.05.

Figure 4.

mRNA expression level of MOS in experimental groups. ‘*’ indicates a significant difference between groups at P < 0.05.

Protein expression

The expression of AKT protein in the treatment group was lower than in the control group. In the treatment group the expression levels of FOXO3a and Bax were significantly higher than in the control group (P < 0.05; Figure 5).

Figure 5.

Western blot analysis of AKT and FOXO3a. Different lowercase letters (a and b) indicate a significant difference between groups.

Discussion

This study showed that adding kisspeptin to FSH-rich culture medium increases maturity in the cumulus–oocyte pig complex that can lead to increased expression of GDF9 and BMP15. Hu et al. (Reference Hu, Zhao, Chang, Yu and Qiao2017) stated that kisspeptin is secreted from puberty, increasing follicle maturation, reducing the number of immature follicles and defects in kisspeptin, and causing primary ovarian insufficiency (POF). Treatment of porcine cumulus–oophorus cells with kisspeptin in culture medium increased the expression of GDF9 and BMP15. Taniguchi et al. (Reference Taniguchi, Kuwahara, Tachibana, Yano, Yano, Yamamoto, Yamasaki, Iwasa, Hinokio, Matsuzaki and Irahara2017) showed that the amount of follicular fluid kisspeptin was directly related to the increase in mature follicles and estradiol. Kisspeptin also increased in the pre-ovulatory and luteal periods and was expressed in growing follicles in granulosa and theca cells. Kisspeptin promoted the maturation of follicles and increased the number of secondary follicles. This finding confirmed previous studies that kisspeptin directly affected the maturity of follicles (Hu et al., Reference Hu, Zhao, Chang, Yu and Qiao2017). An earlier study showed that adding kisspeptin to sheep culture medium increased oocyte maturation.

In conclusion, the results of this study showed that kisspeptin has a stimulating effect on the maturation of human ovarian follicles in culture.

Ethics approval and consent to participate

The present study was extracted from a research project approved by the Men’s Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences. Informed consent was received from all participants.

Acknowledgements

The authors would like to thank all the contributors to this project.

Competing interests

In the present study, the authors did not have any conflict of interest.

Footnotes

Leila Kooshesh and Ali Tayyebiazar contributed equally to this work.

References

Aslan, M., Erkanli Senturk, G., Akkaya, H., Sahin, S. and Yılmaz, B. (2017). The effect of oxytocin and kisspeptin-10 in ovary and uterus of ischemia-reperfusion injured rats. Taiwanese Journal of Obstetrics and Gynecology, 56(4), 456–462. doi: 10.1016/j.tjog.2016.12.018 CrossRefGoogle ScholarPubMed
Cao, Y., Li, Z., Jiang, W., Ling, Y. and Kuang, H. (2019). Reproductive functions of kisspeptin/KISS1R systems in the periphery. Reproductive Biology and Endocrinology, 17(1), 65. doi: 10.1186/s12958-019-0511-x.CrossRefGoogle ScholarPubMed
Choi, J., Lee, J. Y., Lee, E., Yoon, B. K., Bae, D. and Choi, D. (2007). Cryopreservation of the mouse ovary inhibits the onset of primordial follicle development. Cryobiology, 54(1), 55–62. doi: 10.1016/j.cryobiol.2006.11.003 CrossRefGoogle ScholarPubMed
Donnez, J. and Dolmans, M. M. (2017). Fertility preservation in women. New England Journal of Medicine, 377(17), 1657–1665. doi: 10.1056/NEJMra1614676 CrossRefGoogle ScholarPubMed
Ebrahimi, B., Valojerdi, M. R., Eftekhari-Yazdi, P., Baharvand, H. and Farrokhi, A. (2010). IVM and gene expression of sheep cumulus–oocyte complexes following different methods of vitrification. Reproductive Biomedicine Online, 20(1), 26–34. doi: 10.1016/j.rbmo.2009.10.020 CrossRefGoogle ScholarPubMed
Hu, K. L., Zhao, H., Chang, H. M., Yu, Y. and Qiao, J. (2017). Kisspeptin/kisspeptin receptor system in the ovary. Frontiers in Endocrinology, 8, 365. doi: 10.3389/fendo.2017.00365 CrossRefGoogle ScholarPubMed
Jadoul, P., Dolmans, M. M. and Donnez, J. (2010). Fertility preservation in girls during childhood: Is it feasible, efficient and safe and to whom should it be proposed? Human Reproduction Update, 16(6), 617–630. doi: 10.1093/humupd/dmq010 CrossRefGoogle ScholarPubMed
Kona, S. S., Praveen Chakravarthi, V., Siva Kumar, A. V., Srividya, D., Padmaja, K. and Rao, V. H. (2016). Quantitative expression patterns of GDF9 and BMP15 genes in sheep ovarian follicles grown in vivo or cultured in vitro . Theriogenology, 85(2), 315–322. doi: 10.1016/j.theriogenology.2015.09.022 CrossRefGoogle ScholarPubMed
Kotani, M., Detheux, M., Vandenbogaerde, A., Communi, D., Vanderwinden, J. M., Le Poul, E., Brézillon, S., Tyldesley, R., Suarez-Huerta, N., Vandeput, F., Blanpain, C., Schiffmann, S. N., Vassart, G. and Parmentier, M. (2001). The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. Journal of Biological Chemistry, 276(37), 34631–34636. doi: 10.1074/jbc.M104847200 CrossRefGoogle ScholarPubMed
MacManes, M. D., Austin, S. H., Lang, A. S., Booth, A., Farrar, V. and Calisi, R. M. (2017). Widespread patterns of sexually dimorphic gene expression in an avian hypothalamic–pituitary–gonadal (HPG) axis. Scientific Reports, 7(1), 45125. doi: 10.1038/srep45125 CrossRefGoogle Scholar
Mazoochi, T., Salehnia, M., Pourbeiranvand, S., Forouzandeh, M., Mowla, S. J. and Hajizadeh, E. (2009). Analysis of apoptosis and expression of genes related to apoptosis in cultures of follicles derived from vitrified and non-vitrified ovaries. Molecular Human Reproduction, 15(3), 155–164. doi: 10.1093/molehr/gap002 CrossRefGoogle ScholarPubMed
Qin, X., Zhao, Y., Zhang, T., Yin, C., Qiao, J., Guo, W. and Lu, B. (2022, February 17). TrkB agonist antibody ameliorates fertility deficits in aged and cyclophosphamide-induced premature ovarian failure model mice. Nature Communications, 13(1), 914. doi: 10.1038/s41467-022-28611-2 CrossRefGoogle ScholarPubMed
Ramezani, M., Salehnia, M. and Jafarabadi, M. (2017). Short term culture of vitrified human ovarian cortical tissue to assess the cryopreservation outcome: Molecular and morphological analysis. Journal of Reproduction and Infertility, 18(1), 162–171.Google ScholarPubMed
Rivas Leonel, E. C. R., Lucci, C. M. and Amorim, C. A. (2019). Cryopreservation of human ovarian tissue: A review. Transfusion Medicine and Hemotherapy, 46(3), 173–181. doi: 10.1159/000499054 CrossRefGoogle ScholarPubMed
Shi, Q., Xie, Y., Wang, Y. and Li, S. (2017). Vitrification versus slow freezing for human ovarian tissue cryopreservation: A systematic review and meta-analysis. Scientific Reports, 7(1), 8538. doi: 10.1038/s41598-017-09005-7 CrossRefGoogle Scholar
Skorupskaite, K., George, J. T. and Anderson, R. A. (2014). The kisspeptin-GnRH pathway in human reproductive health and disease. Human Reproduction Update, 20(4), 485–500. doi: 10.1093/humupd/dmu009 CrossRefGoogle Scholar
Taghizabet, N., Khalili, M. A., Anbari, F., Agha-Rahimi, A., Nottola, S. A., Macchiarelli, G. and Palmerini, M. G. (2018). Human cumulus cell sensitivity to vitrification, an ultrastructural study. Zygote, 26(3), 224–231. doi: 10.1017/S0967199418000138 Google ScholarPubMed
Taniguchi, Y., Kuwahara, A., Tachibana, A., Yano, Y., Yano, K., Yamamoto, Y., Yamasaki, M., Iwasa, T., Hinokio, K., Matsuzaki, T. and Irahara, M. (2017). Intra-follicular kisspeptin levels are related to oocyte maturation and gonadal hormones in patients who are undergoing assisted reproductive technology. Reproductive Medicine and Biology, 16(4), 380–385. doi: 10.1002/rmb2.12056 CrossRefGoogle ScholarPubMed
Trapphoff, T., Heiligentag, M., Simon, J., Staubach, N., Seidel, T., Otte, K., Fröhlich, T., Arnold, G. J. and Eichenlaub-Ritter, U. (2016). Improved cryotolerance and developmental potential of in vitro and in vivo matured mouse oocytes by supplementing with a glutathione donor prior to vitrification. Molecular Human Reproduction, 22(12), 867–881. doi: 10.1093/molehr/gaw059.Google ScholarPubMed
Wallace, W. H. B., Smith, A. G., Kelsey, T. W., Edgar, A. E. and Anderson, R. A. (2014). Fertility preservation for girls and young women with cancer: Population-based validation of criteria for ovarian tissue cryopreservation. Lancet. Oncology, 15(10), 1129–1136. doi: 10.1016/S1470-2045(14)70334-1 CrossRefGoogle Scholar
Figure 0

Figure 1. mRNA expression levels of BMP15 in experimental groups. Different lowercase letters (a and b) indicate a significant difference between groups.

Figure 1

Table 1. The primer sequences of target genes

Figure 2

Figure 2. mRNA expression levels of GDF9 in experimental groups. Different lowercase letters (a and b) indicate a significant difference between groups.

Figure 3

Figure 3. mRNA expression levels of mTOR in experimental groups. ‘*’ indicates a significant difference between groups at P < 0.05.

Figure 4

Figure 4. mRNA expression level of MOS in experimental groups. ‘*’ indicates a significant difference between groups at P < 0.05.

Figure 5

Figure 5. Western blot analysis of AKT and FOXO3a. Different lowercase letters (a and b) indicate a significant difference between groups.